Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18207-18215
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18207
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18207
Figure 5 Proteasome inhibition by bortezomib treatment inhibits chymotrypsin-like activity.
A: Chymotrypsin-like activity; B: Trypsin-like activity. Values are mean ± SE. aP < 0.05 vs control. TNBS: 2,4,6-trinitrobenzene sulfonic acid; BTZ: Bortezomib.
- Citation: Loeuillard E, Bertrand J, Herranen A, Melchior C, Guérin C, Coëffier M, Aziz M, Déchelotte P, Savoye G, Marion-Letellier R. 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling. World J Gastroenterol 2014; 20(48): 18207-18215
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18207.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18207